» Articles » PMID: 10541437

Secretion of Metalloendopeptidase 24.15 (EC 3.4.24.15)

Overview
Journal DNA Cell Biol
Publisher Mary Ann Liebert
Date 1999 Oct 29
PMID 10541437
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The metalloendopeptidase EP24.15 (EC3.4.24.15) is a neuropeptide-metabolizing enzyme present in neural and endocrine tissues, presumably functioning extracellularly. Because the majority of the EP24.15 activity is identified in the soluble fraction of cellular homogenates, suggesting that the enzyme is primarily an intracellular protein, we addressed the issue of how EP24.15 arrives in the extracellular environment. We utilized a model system of neuroendocrine secretion, the AtT20 cell. According to both enzymatic activity and immunologic assays, EP24.15 was synthesized in and released from AtT20 cells. Under basal conditions and after stimulation by corticotropin-releasing hormone or the calcium ionophore A23187, EP24.15 activity accumulated in the culture medium. This secretion was not attributable to cell damage, as judged by the absence of release of cytosolic enzyme markers and the ability to exclude trypan blue dye. Pulse-chase analysis and subcellular fractionation of AtT20 cell extracts suggested that the mechanism of EP24.15 secretion is not solely via classical secretory pathways. Additionally, drugs which disrupt the classical secretory pathway, such as Brefeldin A and nocodazole, blocked A23187-stimulated EP24.15 release yet had no effect on basal EP24.15 release, suggesting differences in the basal and stimulated pathways of secretion for EP24.15. In summary, EP24.15 appears to be secreted from AtT20 pituitary cells into the extracellular milieu, where the enzyme can participate in the physiologic metabolism of neuropeptides.

Citing Articles

Neurolysin Knockout Mice in a Diet-Induced Obesity Model.

Caprioli B, Eichler R, Silva R, Martucci L, Reckziegel P, Ferro E Int J Mol Sci. 2023; 24(20).

PMID: 37894869 PMC: 10607720. DOI: 10.3390/ijms242015190.


Comparative transcriptome analysis between patient and endometrial cancer cell lines to determine common signaling pathways and markers linked to cancer progression.

Cho-Clark M, Sukumar G, Vidal N, Raiciulescu S, Oyola M, Olsen C Oncotarget. 2021; 12(26):2500-2513.

PMID: 34966482 PMC: 8711572. DOI: 10.18632/oncotarget.28161.


Thimet Oligopeptidase Biochemical and Biological Significances: Past, Present, and Future Directions.

Ferro E, Gewehr M, Navon A Biomolecules. 2020; 10(9).

PMID: 32847123 PMC: 7565970. DOI: 10.3390/biom10091229.


Peptides from Natural or Rationally Designed Sources Can Be Used in Overweight, Obesity, and Type 2 Diabetes Therapies.

Gewehr M, Silverio R, Rosa-Neto J, Lira F, Reckziegel P, Ferro E Molecules. 2020; 25(5).

PMID: 32121443 PMC: 7179135. DOI: 10.3390/molecules25051093.


The Relevance of Thimet Oligopeptidase in the Regulation of Energy Metabolism and Diet-Induced Obesity.

Gewehr M, Teixeira A, Santos B, Biondo L, Gozzo F, Cordibello A Biomolecules. 2020; 10(2).

PMID: 32079362 PMC: 7072564. DOI: 10.3390/biom10020321.